眼科治疗公司 OCUL
$6.60 +$0.17 (+2.57%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.65 +0.86%
开盘$6.53
昨收$6.43
当日区间$6.52 – $6.75
成交量1.96M
市值$1.45B
市盈率（TTM）–
股息率–
OCUL 相关新闻
匹配 Ocular Therapeutix 或代码 OCUL 的头条新闻，按最新排序。
- Needham Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $18
- Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $31
- William Blair Maintains Ocular Therapeutix(OCUL.US) With Buy Rating
- H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $25
- BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $27
- TD Cowen Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $20
- Clear Street Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $28
- RBC Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $30
- Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $23 正面
- A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $31
- Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Ocular Therapeutix (OCUL) 正面
- Baird Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $30 正面
- Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21
- A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $30
- H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21
暂无评论——快来第一个聊聊 OCUL。
登录后参与讨论。